
Quotient Limited QTNT
Quarterly report 2023-Q3
added 05-23-2026
Quotient Limited Total Inventories 2011-2026 | QTNT
Annual Total Inventories Quotient Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 M | 22 M | 23.7 M | 15.6 M | 16.3 M | 13.6 M | 12.6 M | 4.61 M | 4.56 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.7 M | 4.56 M | 15 M |
Quarterly Total Inventories Quotient Limited
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 12.8 M | 22.1 M | 14.3 M | 22.8 M | 25 M | 23.2 M | 22.8 M | 23.7 M | 22.8 M | 21.3 M | 23.7 M | 19.8 M | 18.1 M | 16.7 M | 19.8 M | 15.3 M | 15.3 M | 15.6 M | 15.3 M | 15.3 M | 15.6 M | 16.3 M | 16.5 M | 16.5 M | 15.2 M | 14.8 M | 13.2 M | 7.81 M | 5.83 M | 5.01 M | 7.81 M | 4.59 M | 4.42 M | 4.64 M | 4.59 M | 4.42 M | 4.64 M | 4.56 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25 M | 4.42 M | 14.5 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
830 M | $ 135.53 | 0.11 % | $ 41.2 B | ||
|
Co-Diagnostics
CODX
|
992 K | $ 8.53 | -23.77 % | $ 11.3 M | ||
|
Castle Biosciences
CSTL
|
10.3 M | $ 21.08 | -4.66 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
2.85 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
85.9 M | $ 129.69 | -2.65 % | $ 16.3 B | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 22.82 | 0.53 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 136.07 | -0.53 % | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 1.7 | -5.56 % | $ 7.52 M | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
547 M | $ 162.96 | 2.68 % | $ 25.9 B | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 99.3 | -0.32 % | $ 6.7 B | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
387 M | $ 1 180.58 | 1.47 % | $ 24.3 B | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 180.71 | -0.35 % | $ 8.96 B | ||
|
NeoGenomics
NEO
|
28.6 M | $ 10.52 | 3.24 % | $ 1.35 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
35.4 M | $ 223.37 | 4.41 % | $ 22 B | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 3.97 | -5.92 % | $ 368 M | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 6.79 | 1.04 % | $ 283 M | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
15 M | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
28.3 M | $ 66.87 | -3.13 % | $ 4 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.39 | -1.74 % | $ 5.49 M | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 260.06 | -0.75 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 492.51 | 1.09 % | $ 186 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
191 M | $ 8.97 | -3.55 % | $ 1.95 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 194.9 | -0.72 % | $ 21.6 B | ||
|
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M |